MAPT and Alzheimer disease: The TgF344-AD rat model, developed by Cohen and colleagues (Cohen et al., 2013), expresses human APPswe and PS1ΔE9 mutations and develops age-dependent cerebral amyloidosis, gliosis and phospho-tau pathology (Cohen et al., 2013).